As
people with HIV live longer and are less likely
to die of AIDS-defining illnesses, end-stage liver disease has become an increasingly
important cause of morbidity and mortality in this population.
As
reported in the March 2008 Journal of Viral Hepatitis, Spanish researchers
conducted a retrospective, observational, cross-sectional study to assess the
prevalence of liver cirrhosis,
its main causes, and its clinical presentation in all HIV positive individuals
followed at a single HIV outpatient clinic in Madrid.
Liver
fibrosis was measured using the non-invasive transient elastometry method
(FibroScan). All 2168 HIV positive patients receiving regular follow-up at the
clinic underwent elastometry between October 2004 and August 2006. About three-quarters
(76%) were men and about half (46%) were injection drug users.
Results
181 patients were identified
as having liver cirrhosis, for an overall prevalence rate of 8.3%. The major causes associated
with cirrhosis were:
Based
on these findings, the investigators concluded, "Liver cirrhosis and hepatic
decompensation events are relatively frequent in HIV positive individuals."
In
this study, they continued, "Chronic HCV and alcohol abuse, but not chronic
HBV, play[ed] a major role."
Finally,
they concluded that, "Transient elastometry may allow the identification
of a significant number of HIV positive individuals with asymptomatic liver cirrhosis."
4/11/08
Reference C
Castellares, P Barreiro, L Martin-Carbonero, and others. Liver cirrhosis in HIV-infected
patients: prevalence, aetiology and clinical outcome. Journal of Viral Hepatitis
15(3): 165-172. March 2008.